1. Home
  2. SLDB vs TOI Comparison

SLDB vs TOI Comparison

Compare SLDB & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLDB
  • TOI
  • Stock Information
  • Founded
  • SLDB 2013
  • TOI 2007
  • Country
  • SLDB United States
  • TOI United States
  • Employees
  • SLDB N/A
  • TOI N/A
  • Industry
  • SLDB Biotechnology: Biological Products (No Diagnostic Substances)
  • TOI Medical/Nursing Services
  • Sector
  • SLDB Health Care
  • TOI Health Care
  • Exchange
  • SLDB Nasdaq
  • TOI Nasdaq
  • Market Cap
  • SLDB 464.1M
  • TOI 444.1M
  • IPO Year
  • SLDB 2018
  • TOI N/A
  • Fundamental
  • Price
  • SLDB $4.52
  • TOI $3.32
  • Analyst Decision
  • SLDB Strong Buy
  • TOI Strong Buy
  • Analyst Count
  • SLDB 10
  • TOI 2
  • Target Price
  • SLDB $14.70
  • TOI $6.50
  • AVG Volume (30 Days)
  • SLDB 1.3M
  • TOI 2.9M
  • Earning Date
  • SLDB 11-03-2025
  • TOI 11-13-2025
  • Dividend Yield
  • SLDB N/A
  • TOI N/A
  • EPS Growth
  • SLDB N/A
  • TOI N/A
  • EPS
  • SLDB N/A
  • TOI N/A
  • Revenue
  • SLDB N/A
  • TOI $461,039,000.00
  • Revenue This Year
  • SLDB N/A
  • TOI $21.71
  • Revenue Next Year
  • SLDB N/A
  • TOI $20.58
  • P/E Ratio
  • SLDB N/A
  • TOI N/A
  • Revenue Growth
  • SLDB N/A
  • TOI 21.67
  • 52 Week Low
  • SLDB $2.41
  • TOI $0.13
  • 52 Week High
  • SLDB $7.37
  • TOI $4.88
  • Technical
  • Relative Strength Index (RSI)
  • SLDB 42.74
  • TOI 40.37
  • Support Level
  • SLDB $4.16
  • TOI $3.07
  • Resistance Level
  • SLDB $4.73
  • TOI $4.01
  • Average True Range (ATR)
  • SLDB 0.45
  • TOI 0.38
  • MACD
  • SLDB 0.01
  • TOI -0.07
  • Stochastic Oscillator
  • SLDB 40.63
  • TOI 14.16

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life science company. It is engaged in the manufacturing of specialty and generic drugs. The company is involved in curing Duchenne muscular dystrophy (DMD), a genetic muscle-wasting disease predominantly affecting boys, with symptoms that usually manifest between three and five years of age. The company's pipeline products are the SB-001 and solid suit. The Company's singular focus is on developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases. The company has categorized its programs into corrective therapies, disease-modifying therapies, and assistive devices.

About TOI The Oncology Institute Inc.

The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.

Share on Social Networks: